DATE: September 11, 2018
TO: Board of Supervisors
SUBMITTED BY: David Pomaville, Director, Department of Public Health
SUBJECT: Amendment to Agreement with Diamond Drugs, Inc.
RECOMMENDED ACTION(S):
TITLE
Approve and authorize the Chairman to execute Amendment II to Agreement No. 13-570 with Diamond Drugs, Inc., dba Diamond Pharmacy Services, to extend the term of the existing Agreement for pharmaceutical prescriptions and consultation services by six months from September 17, 2018 to March 17, 2019 with no increase in the maximum of $2,269,310.
REPORT
Approval of the recommended action will allow the Department of Public Health to continue to utilize Diamond Drugs, Inc. (Diamond) for pharmaceutical and consultation services an additional six months allowing the Department to complete a Request for Proposal (RFP) and subsequent contract for services. The amendment is funded with a grant from the California Department of Public Health (CDPH). This item is countywide.
ALTERNATIVE ACTION(S):
There are no viable alternative actions. Should your Board not approve the recommended action, the Department would not have prophylaxis readily available to treat tuberculosis (TB), meningitis, syphilis and other communicable diseases in the community.
FISCAL IMPACT:
There is no increase in Net County Cost associated with the recommended action. The maximum compensation for the final year of the agreement (September 18, 2017 - September 17, 2018) plus the recommended six-month extension (September 18, 2018 - March 17, 2019) shall not exceed $470,000 and will be funded by a California Department of Public Health grant (9%) and Health Realignment (91%). Sufficient appropriations and estimated revenues are included in the Department's Org 5620 FY 2018-19 Recommended Budget.
DISCUSSION:
On September 17, 2013, the Board approved Agreement No. 13-570 with Diamond for pharmaceutical and consultation services. On December 12, 2017, the Board approved an amendment to ...
Click here for full text